Skip to content

Home
About Us
- Board of Directors
- Management Team
Technology
News/Resources
Investor Centre
Contacts

ASX Announcements 2006

22 Dec 2006
Agreement with the ANU and Enhancement of the Antiviral Drug Development Program
15 Dec 2006
BIT225 Presentation at International HIV Meeting, Cancun, Mexico
31 Oct 2006
Anti-HCV Compound Presentation to International Meeting, Boston USA
20 Oct 2006
Presentation to Annual General Meeting
20 Oct 2006
Results of Annual General Meeting
19 Oct 2006
Quarterly Report 30 September 2006
21 Sep 2006
Annual report for the year ended 30 June 2006
20 Sep 2006
Biotron Compounds Show HCV Activity
13 Sep 2006
Preliminary Final Report 30 June 2006
18 Jul 2006
Quarterly Report 30 June 2006
11 Jul 2006
Manufacture of Biotron’s Anti-HIV Drug BIT225
27 Jun 2006
Presentation of Company Activities
2 May 2006
Directors’ Interests
20 Apr 2006
Quarterly Report 31 March 2006
23 Mar 2006
Revised Entitlement Issue Timetable
22 Mar 2006
Prospectus 2006
15 Mar 2006
New Issues Announcement
15 Mar 2006
Interim Financial Report 31 December 2005
7 Mar 2006
Half-year report 31 December 2005
24 Feb 2006
Biotron Compounds Active Against Bird Flu
30 Jan 2006
Quarterly Report 31 December 2005

<<
2025
2024

2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
>>

Investor Centre

Investor Centre

© Biotron Limited 2016 ABN 60 086 399 144 Site updated 24 April 2025 Legal Notices and Privacy